|
(a) Schedule I shall consist of the drugs and other substances,
by whatever official name, common or usual name, chemical name, or
brand name designated, listed in this section. Each drug or
substance has been assigned the DEA Controlled Substances Code
Number set forth opposite it.
(b) Opiates. Unless specifically excepted or unless
listed in another schedule, any of the following opiates, including
their isomers, esters, ethers, salts, and salts of isomers, esters
and ethers, whenever the existence of such isomers, esters, ethers
and salts is possible within the specific chemical designation (for
purposes of 3-methylthiofentanyl only, the term isomer includes the
optical and geometric isomers):
| (1)
Acetyl-alpha-methylfentanyl
(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide) |
9815 |
| (2)
Acetylmethadol |
9601 |
| (3) Acetyl
fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) |
9821 |
| (4) Acryl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; other name:
acryloylfentanyl) |
9811 |
| (5) AH-7921
(3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl]benzamide |
9551 |
| (6)
Allylprodine |
9602 |
| (7)
Alphacetylmethadol (except levo-alphacetylmethadol also known as
levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM) |
9603 |
| (8)
Alphameprodine |
9604 |
| (9)
Alphamethadol |
9605 |
| (10)
Alpha-methylfentanyl
(N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide;
1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine) |
9814 |
| (11)
Alpha-methylthiofentanyl
(N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) |
9832 |
| (12)
Benzethidine |
9606 |
| (13)
Betacetylmethadol |
9607 |
| (14)
Beta-hydroxyfentanyl
(N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide) |
9830 |
| (15)
Beta-hydroxy-3-methylfentanyl (other name:
N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide |
9831 |
| (16)
N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide
(Other name: beta-Hydroxythiofentanyl) |
9836 |
| (17)
Betameprodine |
9608 |
| (18)
Betamethadol |
9609 |
| (19)
Betaprodine |
9611 |
| (20) Butyryl
fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide) |
9822 |
| (21)
Clonitazene |
9612 |
| (22) Cyclopentyl
fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide) |
9847 |
| (23) Cyclopropyl
fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide) |
9845 |
| (24)
Dextromoramide |
9613 |
| (25)
Diampromide |
9615 |
| (26)
Diethylthiambutene |
9616 |
| (27)
Difenoxin |
9168 |
| (28)
Dimenoxadol |
9617 |
| (29)
Dimepheptanol |
9618 |
| (30)
Dimethylthiambutene |
9619 |
| (31) Dioxaphetyl
butyrate |
9621 |
| (32)
Dipipanone |
9622 |
| (33)
Ethylmethylthiambutene |
9623 |
| (34)
Etonitazene |
9624 |
| (35)
Etoxeridine |
9625 |
| (36)
4-Fluoroisobutyryl fentanyl
(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide;
other name: para-fluoroisobutyryl fentanyl) |
9824 |
| (37) Furanyl
fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) |
9834 |
| (38)
Furethidine |
9626 |
| (39)
Hydroxypethidine |
9627 |
| (40) Isobutyryl
fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide) |
9827 |
| (41)
Levomoramide |
9629 |
| (42)
Levophenacylmorphan |
9631 |
| (43) Methoxyacetyl
fentanyl
(2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) |
9825 |
| (44)
3-Methylfentanyl
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide) |
9813 |
| (45)
3-methylthiofentanyl
(N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) |
9833 |
| (46)
Morpheridine |
9632 |
| (47) MPPP
(1-methyl-4-phenyl-4-propionoxypiperidine) |
9661 |
| (48) MT-45
(1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) |
(9560) |
| (49)
Noracymethadol |
9633 |
| (50)
Norlevorphanol |
9634 |
| (51)
Normethadone |
9635 |
| (52)
Norpipanone |
9636 |
| (53) Ocfentanil
(N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide) |
9838 |
| (54)
ortho-Fluorofentanyl
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);
other name: 2-fluorofentanyl) |
9816 |
| (55)
para-Fluorobutyryl fentanyl
(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) |
9823 |
| (56)
para-Chloroisobutyryl fentanyl
(N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide |
9826 |
| (57) PEPAP
(1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine |
9663 |
| (58)
Phenadoxone |
9637 |
| (59)
para-Methoxybutyryl fentanyl
(N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) |
9837 |
| (60)
Phenomorphan |
9647 |
| (61)
Phenoperidine |
9641 |
| (62)
Piritramide |
9642 |
| (63)
Proheptazine |
9643 |
| (64)
Properidine |
9644 |
| (65) Propiram |
9649 |
| (66)
Racemoramide |
9645 |
| (67)
Tetrahydrofuranyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide) |
9843 |
| (68) Thiofentanyl
(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide |
9835 |
| (69) Tilidine |
9750 |
| (70)
Trimeperidine |
9646 |
| (71) U-47700
(3,4-Dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) |
9547 |
| (75) Valeryl
fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide) |
9840 |
(c) Opium derivatives. Unless specifically excepted or
unless listed in another schedule, any of the following opium
derivatives, its salts, isomers, and salts of isomers whenever the
existence of such salts, isomers, and salts of isomers is possible
within the specific chemical designation:
| (1)
Acetorphine |
9319 |
| (2)
Acetyldihydrocodeine |
9051 |
| (3)
Benzylmorphine |
9052 |
| (4) Codeine
methylbromide |
9070 |
| (5)
Codeine-N-Oxide |
9053 |
| (6)
Cyprenorphine |
9054 |
| (7)
Desomorphine |
9055 |
| (8)
Dihydromorphine |
9145 |
| (9)
Drotebanol |
9335 |
| (10) Etorphine
(except hydrochloride salt) |
9056 |
| (11) Heroin |
9200 |
| (12)
Hydromorphinol |
9301 |
| (13)
Methyldesorphine |
9302 |
| (14)
Methyldihydromorphine |
9304 |
| (15) Morphine
methylbromide |
9305 |
| (16) Morphine
methylsulfonate |
9306 |
| (17)
Morphine-N-Oxide |
9307 |
| (18)
Myrophine |
9308 |
| (19)
Nicocodeine |
9309 |
| (20)
Nicomorphine |
9312 |
| (21)
Normorphine |
9313 |
| (22)
Pholcodine |
9314 |
| (23) Thebacon |
9315 |
(d) Hallucinogenic substances. Unless specifically
excepted or unless listed in another schedule, any material,
compound, mixture, or preparation, which contains any quantity of
the following hallucinogenic substances, or which contains any of
its salts, isomers, and salts of isomers whenever the existence of
such salts, isomers, and salts of isomers is possible within the
specific chemical designation (for purposes of this paragraph only,
the term “isomer” includes the optical, position and geometric
isomers):
| (1)
Alpha-ethyltryptamine |
7249 |
| Some trade or
other names: etryptamine; Monase; a-ethyl-1H-indole-3-ethanamine;
3-(2-aminobutyl) indole; a-ET; and AET. |
|
| (2)
4-bromo-2,5-dimethoxy-amphetamine |
7391 |
| Some trade or
other names: 4-bromo-2,5-dimethoxy-a-methylphenethylamine;
4-bromo-2,5-DMA |
|
| (3)
4-Bromo-2,5-dimethoxyphenethylamine |
7392 |
| Some trade or
other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane;
alpha-desmethyl DOB; 2C-B, Nexus. |
|
| (4)
2,5-dimethoxyamphetamine |
7396 |
| Some trade or
other names: 2,5-dimethoxy-a-methylphenethylamine; 2,5-DMA |
|
| (5)
2,5-dimethoxy-4-ethylamphet-amine |
7399 |
| Some trade or
other names: DOET |
|
| (6)
2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name:
2C-T-7) |
7348 |
| (7)
4-methoxyamphetamine |
7411 |
| Some trade or
other names: 4-methoxy-a-methylphenethylamine;
paramethoxyamphetamine, PMA |
|
| (8)
5-methoxy-3,4-methylenedioxy-amphetamine |
7401 |
| (9)
4-methyl-2,5-dimethoxy-amphetamine |
7395 |
| Some trade and
other names: 4-methyl-2,5-dimethoxy-a-methylphenethylamine; “DOM”;
and “STP” |
|
| (10)
3,4-methylenedioxy amphetamine |
7400 |
| (11)
3,4-methylenedioxymethamphetamine (MDMA) |
7405 |
| (12)
3,4-methylenedioxy-N-ethylamphetamine (also known as
N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl
MDA, MDE, MDEA |
7404 |
| (13)
N-hydroxy-3,4-methylenedioxyamphetamine (also known as
N-hydroxy-alpha-methyl-3,4(methylenedioxy)-phenethylamine, and
N-hydroxy MDA |
7402 |
| (14)
3,4,5-trimethoxy amphetamine |
7390 |
| (15)
5-methoxy-N,N-dimethyltryptamine Some trade or other names:
5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT |
7431 |
| (16)
Alpha-methyltryptamine (other name: AMT) |
7432 |
| (17)
Bufotenine |
7433 |
| Some trade and
other names: 3-(ß-Dimethylaminoethyl)-5-hydroxyindole;
3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin;
5-hydroxy-N,N-dimethyltryptamine; mappine |
|
| (18)
Diethyltryptamine |
7434 |
| Some trade and
other names: N,N-Diethyltryptamine; DET |
|
| (19)
Dimethyltryptamine |
7435 |
| Some trade or
other names: DMT |
|
| (20)
5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT) |
7439 |
| (21) Ibogaine |
7260 |
| Some trade and
other names:
7-Ethyl-6,6ß,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido
[1', 2':1,2] azepino [5,4-b] indole; Tabernanthe iboga |
|
| (22) Lysergic acid
diethylamide |
7315 |
| (23)
Marihuana |
7360 |
| (24)
Mescaline |
7381 |
| (25) Parahexyl -
7374; some trade or other names:
3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran;
Synhexyl. |
|
| (26) Peyote |
7415 |
| Meaning all
parts of the plant presently classified botanically as Lophophora
williamsii Lemaire, whether growing or not, the seeds thereof, any
extract from any part of such plant, and every compound,
manufacture, salts, derivative, mixture, or preparation of such
plant, its seeds or extracts |
|
| (Interprets 21
USC 812(c), Schedule I(c) (12)) |
|
| (27)
N-ethyl-3-piperidyl benzilate |
7482 |
| (28)
N-methyl-3-piperidyl benzilate |
7484 |
| (29)
Psilocybin |
7437 |
| (30) Psilocyn |
7438 |
| (31)
Tetrahydrocannabinols |
7370 |
| (i) Meaning
tetrahydrocannabinols, except as in paragraph (d)(31)(ii) of this
section, naturally contained in a plant of the genus Cannabis
(cannabis plant), as well as synthetic equivalents of the
substances contained in the cannabis plant, or in the resinous
extractives of such plant, and/or synthetic substances,
derivatives, and their isomers with similar chemical structure and
pharmacological activity to those substances contained in the
plant, such as the following: |
|
| 1 cis or trans
tetrahydrocannabinol, and their optical isomers |
|
| 6 cis or trans
tetrahydrocannabinol, and their optical isomers |
|
| 3, 4 cis or
trans tetrahydrocannabinol, and its optical isomers |
|
| (Since
nomenclature of these substances is not internationally
standardized, compounds of these structures, regardless of
numerical designation of atomic positions covered.) |
|
| (ii)
Tetrahydrocannabinols does not include any material, compound,
mixture, or preparation that falls within the definition of hemp
set forth in 7 U.S.C. 1639o. |
|
| (32) Ethylamine
analog of phencyclidine |
7455 |
| Some trade or
other names: N-ethyl-1-phenylcyclohexylamine,
(1-phenylcyclohexyl)ethylamine, N-(1-phenylcyclohexyl)ethylamine,
cyclohexamine, PCE |
|
| (33) Pyrrolidine
analog of phencyclidine |
7458 |
| Some trade or
other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP |
|
| (34) Thiophene
analog of phencyclidine |
7470 |
| Some trade or
other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine,
2-thienylanalog of phencyclidine, TPCP, TCP |
|
| (35)
1-[1-(2-thienyl)cyclohexyl]pyrrolidine |
7473 |
| Some other
names: TCPy |
|
| (36)
4-methylmethcathinone (Mephedrone) |
1248 |
| (37)
3,4-methylenedioxypyrovalerone (MDPV) |
7535 |
| (38)
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) |
7509 |
| (39)
2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) |
7508 |
| (40)
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) |
7519 |
| (41)
2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) |
7518 |
| (42)
2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) |
7385 |
| (43)
2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) |
7532 |
| (44)
2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) |
7517 |
| (45)
2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) |
7521 |
| (46)
2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) |
7524 |
| (47)
3,4-Methylenedioxy-N-methylcathinone (Methylone) |
7540 |
| (48)
(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
(UR-144) |
(7144) |
| (49)
[1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
(5-fluoro-UR-144, XLR11) |
(7011) |
| (50)
N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA,
AKB48) |
(7048) |
| (51) quinolin-8-yl
1-pentyl-1H-indole-3-carboxylate (PB-22; QUPIC) |
(7222) |
| (52) quinolin-8-yl
1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22;
5F-PB-22) |
(7225) |
| (53)
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
(AB-FUBINACA) |
(7012) |
| (54)
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide
(ADB-PINACA) |
(7035) |
| (55)
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
(25I-NBOMe, 2C-I-NBOMe) |
(7538) |
| (56)
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
(25C-NBOMe, 2C-C-NBOMe) |
(7537) |
| (57)
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
(25B-NBOMe, 2C-B-NBOMe) |
(7536) |
| (58) Marihuana
Extract |
7350 |
| Meaning an
extract containing one or more cannabinoids that has been derived
from any plant of the genus Cannabis, containing greater than 0.3%
delta-9-tetrahydrocannabinol on a dry weight basis, other than the
separated resin (whether crude or purified) obtained from the
plant. |
|
| (59)
4-methyl-N-ethylcathinone (4-MEC) |
(1249) |
| (60)
4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP) |
(7498) |
| (61)
alpha-pyrrolidinopentiophenone (a-PVP) |
(7545) |
| (62)
1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone,
bk-MBDB) |
(7541) |
| (63)
2-(methylamino)-1-phenylpentan-1-one (pentedrone) |
(1246) |
| (64)
1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone,
bk-MBDP) |
(7542) |
| (65)
4-fluoro-N-methylcathinone (4-FMC; flephedrone) |
(1238) |
| (66)
3-fluoro-N-methylcathinone (3-FMC) |
(1233) |
| (67)
1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one
(naphyrone) |
(1258) |
| (68)
alpha-pyrrolidinobutiophenone (a-PBP) |
(7546) |
| (69)
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
(AB-CHMINACA) |
(7031) |
| (70)
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide
(AB-PINACA) |
(7023) |
| (71)
[1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone
(THJ-2201) |
(7024) |
| (72)
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
(MAB-CHMINACA; ADB-CHMINACA) |
(7032) |
| (73) methyl
2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate
(Other names: 5F-ADB; 5F-MDMB-PINACA) |
7034 |
| (74) methyl
2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate
(Other names: 5F-AMB) |
7033 |
| (75)
N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide
(Other names: 5F-APINACA, 5F-AKB48) |
7049 |
| (76)
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
(Other names: ADB-FUBINACA) |
7010 |
| (77) methyl
2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate
(Other names: MDMB-CHMICA, MMB-CHMINACA) |
7042 |
| (78) methyl
2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate
(Other names: MDMB-FUBINACA) |
7020 |
| (79) methyl
2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate,
(FUB-AMB, MMB-FUBINACA, AMB-FUBINACA) |
(7021) |
| (80)
1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone) |
7547 |
(e) Depressants. Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances
having a depressant effect on the central nervous system, including
its salts, isomers, and salts of isomers whenever the existence of
such salts, isomers, and salts of isomers is possible within the
specific chemical designation:
| (1)
gamma-hydroxybutyric acid (some other names include GHB;
gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid;
sodium oxybate; sodium oxybutyrate) |
2010 |
| (2)
Mecloqualone |
2572 |
| (3)
Methaqualone |
2565 |
(f) Stimulants. Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances
having a stimulant effect on the central nervous system, including
its salts, isomers, and salts of isomers:
| (1) Aminorex (Some
other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
4,5-dihydro-5-phenly-2-oxazolamine) |
1585 |
| (2)
N-Benzylpiperazine (some other names: BZP, 1-benzylpiperazine) |
7493 |
| (3) Cathinone |
1235 |
| Some trade or
other names: 2-amino-1-phenyl-1-propanone,
alpha-aminopropiophenone, 2-aminopropiophenone, and
norephedrone |
|
| (4)
Fenethylline |
1503 |
| (5) Methcathinone
(Some other names: 2-(methylamino)-propiophenone;
alpha-(methylamino)propiophenone;
2-(methylamino)-1-phenylpropan-1-one;
alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone;
N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and
UR1432), its salts, optical isomers and salts of optical
isomers |
1237 |
| (6)
(±)cis-4-methylaminorex
((±)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine) |
1590 |
| (7)
N-ethylamphetamine |
1475 |
| (8)
N,N-dimethylamphetamine (also known as
N,N-alpha-trimethyl-benzeneethanamine;
N,N-alpha-trimethylphenethylamine) |
1480 |
(g) Cannabimimetic agents. Unless specifically exempted
or unless listed in another schedule, any material, compound,
mixture, or preparation which contains any quantity of the
following substances, or which contains their salts, isomers, and
salts of isomers whenever the existence of such salts, isomers, and
salts of isomers is possible within the specific chemical
designation:
| (1)
5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
(CP-47,497) |
7297 |
| (2)
5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
(cannabicyclohexanol or CP-47,497 C8-homolog) |
7298 |
| (3)
1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) |
7118 |
| (4)
1-butyl-3-(1-naphthoyl)indole (JWH-073) |
7173 |
| (5)
1-hexyl-3-(1-naphthoyl)indole (JWH-019) |
7019 |
| (6)
1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200) |
7200 |
| (7)
1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250) |
6250 |
| (8)
1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081) |
7081 |
| (9)
1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122) |
7122 |
| (10)
1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398) |
7398 |
| (11)
1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) |
7201 |
| (12)
1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694) |
7694 |
| (13)
1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4) |
7104 |
| (14)
1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole 7008 (SR-18 and
RCS-8) |
7008 |
| (15)
1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203) |
7203 |
(h) Temporary listing of substances subject to emergency
scheduling. Any material, compound, mixture or preparation
which contains any quantity of the following substances:
| (1)-(29)
[Reserved] |
|
| (30)
Fentanyl-related substances, their isomers, esters, ethers, salts
and salts of isomers, esters and ethers |
9850 |
(i) Fentanyl-related substance means any substance not otherwise
listed under another Administration Controlled Substance Code
Number, and for which no exemption or approval is in effect under
section 505 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C.
355], that is structurally related to fentanyl by one or more of
the following modifications:
(A) Replacement of the phenyl portion of the phenethyl group by
any monocycle, whether or not further substituted in or on the
monocycle;
(B) Substitution in or on the phenethyl group with alkyl,
alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro
groups;
(C) Substitution in or on the piperidine ring with alkyl,
alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino or
nitro groups;
(D) Replacement of the aniline ring with any aromatic monocycle
whether or not further substituted in or on the aromatic monocycle;
and/or
(E) Replacement of the N-propionyl group by another acyl
group.
(ii) This definition includes, but is not limited to, the
following substances: (A)-(B) [Reserved]
| (31)
Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate, its
optical, positional, and geometric isomers, salts and salts of
isomers (Other names: NM2201; CBL2201) |
(7221) |
| (32)
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide,
its optical, positional, and geometric isomers, salts and salts of
isomers (Other names: 5F-AB-PINACA) |
(7025) |
| (33)
1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide,
its optical, positional, and geometric isomers, salts and salts of
isomers (Other names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA;
4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78) |
(7089) |
| (34) methyl
2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate,
its optical, positional, and geometric isomers, salts and salts of
isomers (Other names: MMB-CHMICA, AMB-CHMICA) |
(7044) |
| (35)
1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide,
its optical, positional, and geometric isomers, salts and salts of
isomers (Other names: 5F-CUMYL-P7AICA) |
(7085) |
| (36)
N-Ethylpentylone, its optical, positional, and geometric isomers,
salts and salts of isomers (Other names: ephylone,
1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) |
(7543) |
| (37) ethyl
2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate,
its optical, positional, and geometric isomers, salts and salts of
isomers (trivial name: 5F-EDMB-PINACA) |
7036 |
| (38) methyl
2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate,
its optical, positional, and geometric isomers, salts and salts of
isomers (trivial name: 5F-MDMB-PICA) |
7041 |
| (39)
N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide,
its optical, positional, and geometric isomers, salts and salts of
isomers (trivial names: FUB-AKB48; FUB-APINACA; AKB48
N-(4-FLUOROBENZYL)) |
7047 |
| (40)
1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide,
its optical, positional, and geometric isomers, salts and salts of
isomers (trivial names: 5F-CUMYL-PINACA; SGT-25) |
7083 |
| (41)
(1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)
methanone, its optical, positional, and geometric isomers, salts
and salts of isomers (trivial name: FUB-144) |
7014 |
| (42)
N-Ethylhexedrone, its optical, positional, and geometric isomers,
salts and salts of isomers (Other name:
2-(ethylamino)-1-phenylhexan-1-one) |
7246 |
| (43)
alpha-Pyrrolidinohexanophenone, its optical, positional, and
geometric isomers, salts and salts of isomers (Other names: a-PHP;
alpha-pyrrolidinohexiophenone;
1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one) |
7544 |
| (44)
4-Methyl-alpha-ethylaminopentiophenone, its optical, positional,
and geometric isomers, salts and salts of isomers (Other names:
4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one) |
7245 |
| (45)
4'-Methyl-alpha-pyrrolidinohexiophenone, its optical, positional,
and geometric isomers, salts and salts of isomers (Other names:
MPHP; 4'-methyl-alpha-pyrrolidinohexanophenone;
1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one) |
7446 |
| (46)
alpha-Pyrrolidinoheptaphenone, its optical, positional, and
geometric isomers, salts and salts of isomers (Other names: PV8;
1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one) |
7548 |
| (47)
4'-Chloro-alpha-pyrrolidinovalerophenone, its optical, positional,
and geometric isomers, salts and salts of isomers (Other names:
4-chloro-a-PVP; 4'-chloro-alpha-pyrrolidinopentiophenone;
1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one) |
7443 |
| (48)
N,N-diethyl-2-(2-(4
isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine, its
isomers, esters, ethers, salts and salts of isomers, esters and
ethers (Other names: isotonitazene;
N,N-diethyl-2-<4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine) |
9614 |
[39 FR 22141, June 20, 1974] Editorial Note:For Federal Register
citations affecting § 1308.11, see the List of CFR Sections
Affected, which appears in the Finding Aids section of the printed
volume and at www.govinfo.gov. Effective Date Notes:1. At 83
FR 31882, July 10, 2018, § 1308.11 was amended by adding paragraphs
(h)(31) through (h)(35) effective July 10, 2018, through July 10,
2020. At 85 FR 42296, July 13, 2020, the effective period was
extended to July 10, 2021, effective July 10, 2020.
2. At 83 FR 44478, Aug. 31, 2018, § 1308.11 was amended by
adding paragraph (h)(36) effective Aug. 31, 2018, through Aug. 31,
2020. At 85 FR 52915, Aug. 27, 2020, the effective period was
extended to Aug. 31, 2021.
3. At 84 FR 15511, Apr. 16, 2019, § 1308.11 was amended by
adding paragraphs (h)(37) through (h)(41) effective Apr. 16, 2019,
through Apr. 16, 2021.
4. At 84 FR 34297, July 17, 2019, § 1308.11 was amended by
adding paragraphs (h)(42) through (h)(47) effective July 18, 2019,
through July 18, 2021.
5.At 83 FR 5191, Feb. 6, 2018, § 1308.11 was amended by adding
paragraph (h)(30), effective Feb. 6, 2018, through Feb. 6, 2020.
Effective Feb. 6, 2020, Congress extended the effective period for
paragraph (h)(30) until May 6, 2021, by Public Law 116-114.
6. At 85 51346, Aug. 20, 2020, § 1308.11 was amended by adding
paragraph (h)(48), effective Aug. 20, 2020, through Aug. 20,
2022.
|
